Literature DB >> 29589994

Concurrent Milk Ingestion Decreases Absorption of Levothyroxine.

Deborah A Chon1,2, Tamar Reisman1,2, Jane E Weinreb1,2, Jerome M Hershman1,2, Angela M Leung1,2.   

Abstract

BACKGROUND: Levothyroxine is the most commonly prescribed medication in the United States. Many foods and medications, including calcium supplements, can interfere with levothyroxine absorption. No studies have investigated the effect of cow's milk, a common breakfast staple, on the absorption of oral levothyroxine. Cow's milk contains approximately 450 mg of elemental calcium per 12 oz (355 mL) serving.
METHODS: A pharmacokinetic study was conducted in healthy euthyroid subjects to assess levothyroxine absorption with and without concurrent cow's milk consumption. Following an overnight fast, serum total thyroxine (TT4) concentrations were measured at baseline and at one, two, four, and six hours after ingestion of 1000 μg of oral levothyroxine alone or when co-administered with 12 oz (355 mL) of 2% milk. There was a four-week washout period between the two assessments in each subject.
RESULTS: Ten subjects (Mage ± SD = 33.7 ± 10.2 years; 60% male) completed the study. The area under the curve (AUC) of TT4 concentrations was significantly lower when levothyroxine was ingested along with 12 oz (355 mL) of 2% cow's milk (M ± SD = 67.3 ± 12.1) compared to that with levothyroxine alone (73.5 ± 17.0; p = 0.02). Also, peak serum TT4 concentrations were significantly lower when cow's milk was co-administered with levothyroxine (M ± SD = 14.1 ± 0.8 μg/dL) than with levothyroxine alone (13.0 ± 0.9 μg/dL; p = 0.04).
CONCLUSIONS: This is the first study to demonstrate that concurrent cow's milk ingestion reduces oral levothyroxine absorption. The findings support previous literature showing the interference of elemental calcium and food with thyroid hormone absorption. Patients managed with thyroid hormone should be advised to avoid taking their levothyroxine simultaneously with cow's milk.

Entities:  

Keywords:  LT4; absorption; hypothyroidism; levothyroxine; milk; thyroid

Mesh:

Substances:

Year:  2018        PMID: 29589994      PMCID: PMC5905419          DOI: 10.1089/thy.2017.0428

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  26 in total

1.  Oral liquid levothyroxine solves the problem of tablet levothyroxine malabsorption due to concomitant intake of multiple drugs.

Authors:  Roberto Vita; Flavia Di Bari; Salvatore Benvenga
Journal:  Expert Opin Drug Deliv       Date:  2017-02-13       Impact factor: 6.648

2.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

3.  Levothyroxine overuse: time for an about face?

Authors:  Rene Rodriguez-Gutierrez; Spyridoula Maraka; Naykky Singh Ospina; Victor M Montori; Juan P Brito
Journal:  Lancet Diabetes Endocrinol       Date:  2016-10-28       Impact factor: 32.069

4.  The acute effect of calcium carbonate on the intestinal absorption of levothyroxine.

Authors:  N Singh; S L Weisler; J M Hershman
Journal:  Thyroid       Date:  2001-10       Impact factor: 6.568

5.  Ferrous sulfate-induced increase in requirement for thyroxine in a patient with primary hypothyroidism.

Authors:  K M Shakir; J P Chute; B S Aprill; A A Lazarus
Journal:  South Med J       Date:  1997-06       Impact factor: 0.954

6.  The influence of cholestyramine on thyroxine absorption.

Authors:  R C Northcutt; J N Stiel; J W Hollifield; E G Stant
Journal:  JAMA       Date:  1969-06-09       Impact factor: 56.272

7.  Absorption of levothyroxine when coadministered with various calcium formulations.

Authors:  Isabelle Zamfirescu; Harold E Carlson
Journal:  Thyroid       Date:  2011-05       Impact factor: 6.568

8.  Altered intestinal absorption of L-thyroxine caused by coffee.

Authors:  Salvatore Benvenga; Luigi Bartolone; Maria Angela Pappalardo; Antonia Russo; Daniela Lapa; Grazia Giorgianni; Giovanna Saraceno; Francesco Trimarchi
Journal:  Thyroid       Date:  2008-03       Impact factor: 6.568

9.  Sucralfate causes malabsorption of L-thyroxine.

Authors:  S I Sherman; E T Tielens; P W Ladenson
Journal:  Am J Med       Date:  1994-06       Impact factor: 4.965

10.  The Economic Impact of Levothyroxine Dose Adjustments: the CONTROL HE Study.

Authors:  Frank R Ernst; Peri Barr; Riad Elmor; Walter Sandulli; Lionel Thevathasan; Arnold B Sterman; Jessica Goldenberg; Kevin Vora
Journal:  Clin Drug Investig       Date:  2017-01       Impact factor: 2.859

View more
  9 in total

Review 1.  Seeking optimization of LT4 treatment in patients with differentiated thyroid cancer.

Authors:  Ilaria Stramazzo; Silvia Capriello; Alessandro Antonelli; Poupak Fallahi; Marco Centanni; Camilla Virili
Journal:  Hormones (Athens)       Date:  2022-06-02       Impact factor: 2.885

2.  Levothyroxine treatment and gastric juice pH in humans: the proof of concept.

Authors:  Camilla Virili; Giovanni Bruno; Maria Giulia Santaguida; Lucilla Gargano; Ilaria Stramazzo; Corrado De Vito; Alessia Cicenia; Giulia Scalese; Barbara Porowska; Carola Severi; Marco Centanni
Journal:  Endocrine       Date:  2022-04-27       Impact factor: 3.925

3.  Evaluation of evening versus morning levothyroxine intake in elderly (MONIALE).

Authors:  Karina Giassi; Vanessa Piccoli; Ticiana da Costa Rodrigues; Renato Gorga Bandeira de Mello
Journal:  Trials       Date:  2019-12-17       Impact factor: 2.279

Review 4.  Levothyroxine Therapy in Gastric Malabsorptive Disorders.

Authors:  Camilla Virili; Nunzia Brusca; Silvia Capriello; Marco Centanni
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-28       Impact factor: 5.555

Review 5.  L-T4 Therapy in Enteric Malabsorptive Disorders.

Authors:  Poupak Fallahi; Silvia Martina Ferrari; Giusy Elia; Francesca Ragusa; Sabrina Rosaria Paparo; Alessandro Antonelli
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-23       Impact factor: 5.555

Review 6.  Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults.

Authors:  Philippe Caron; Solange Grunenwald; Luca Persani; Françoise Borson-Chazot; Remy Leroy; Leonidas Duntas
Journal:  Rev Endocr Metab Disord       Date:  2021-10-20       Impact factor: 9.306

Review 7.  An Overview on Different L-Thyroxine (l-T4) Formulations and Factors Potentially Influencing the Treatment of Congenital Hypothyroidism During the First 3 Years of Life.

Authors:  Stefano Stagi; Giovanna Municchi; Marta Ferrari; Malgorzata Gabriela Wasniewska
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

Review 8.  Levothyroxine Interactions with Food and Dietary Supplements-A Systematic Review.

Authors:  Agnieszka Wiesner; Danuta Gajewska; Paweł Paśko
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-02

9.  Over-the-counter protein supplement resulting in impaired thyroxine absorption in a hypothyroid patient.

Authors:  P A D M Kumarathunga; N S Kalupahana; C N Antonypillai
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2021-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.